Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR.
Live, attenuated Vibrio cholerae vaccines can induce potent immune responses after only a single oral dose. The strategy of harnessing these strains to present antigens from heterologous pathogens to the mucosal immune system shows great promise. To fully realize this possibility, V. cholerae strains must be created that stably express antigens in vivo in sufficient quantity to generate an immune response. In vivo-induced promoters have been shown to increase the stability and immunogenicity of foreign antigens expressed from multicopy plasmids. We report the construction of a series of genetically stabilized plasmids expressing luciferase as a heterologous protein from the following in vivo-induced promoters: V. cholerae P(argC), P(fhuC) and P(vca1008), and Salmonella enterica serovar Typhi P(ompC). We demonstrate that several of these expression plasmids meet two critical criteria for V. cholerae live vector vaccine studies. First, the plasmids are highly stable in the V. cholerae vaccine strain CVD 103-HgR at low copy number, in the absence of selective pressure. Second, real-time bioluminescent imaging (BLI) demonstrates inducible in vivo expression of the promoters in the suckling mouse model of V. cholerae colonization. Moreover, the use of BLI allows for direct quantitative comparison of in vivo expression from four different promoters at various time points.
Morin
Cara E
CE
Department of Microbiology & Immunology, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Kaper
James B
JB
D000818:Animals; D019677:Artificial Gene Fusion; D022121:Cholera Vaccines / Q000235:genetics*; D015964:Gene Expression Regulation, Bacterial; D017930:Genes, Reporter; D042822:Genomic Instability; D008156:Luciferases / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D010957:Plasmids; D011401:Promoter Regions, Genetic; D012485:Salmonella typhi / Q000235:genetics
D022121:Cholera Vaccines; C414990:cholera vaccine CVD 103-HgR; D008156:Luciferases
Infect Immun. 2005 Feb;73(2):972-80
15664940
Vaccine. 1997 Apr-May;15(6-7):700-8
9178472
Infect Immun. 2003 Oct;71(10):5498-504
14500467
Immunol Lett. 2005 Mar 15;97(2):181-8
15752556
Infect Immun. 1992 Sep;60(9):3916-7
1500200
Methods Mol Biol. 2008;415:101-18
18370150
Microbiol Rev. 1986 Sep;50(3):314-52
3534538
Biotechnol Lett. 2008 Apr;30(4):571-9
18008168
Trends Microbiol. 2001 Aug;9(8):372-6
11514219
Dev Biol Stand. 1995;84:237-44
7796960
Infect Immun. 1996 Oct;64(10):4373-7
8926115
Vaccine. 1990 Dec;8(6):577-80
2087879
FEMS Microbiol Lett. 1990 Mar 1;56(1-2):149-54
2332153
Infect Immun. 1997 Jun;65(6):2127-35
9169742
Cell Host Microbe. 2007 Oct 11;2(4):264-77
18005744
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8508-13
12826608
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6889-94
11391007
Vaccine. 1996 Apr;14(6):545-52
8782354
Infect Immun. 2001 Dec;69(12):7493-500
11705925
Science. 2004 Feb 6;303(5659):851-3
14764883
Infect Immun. 2005 Dec;73(12):8167-78
16299312
Infect Immun. 2001 May;69(5):3150-8
11292735
Trends Microbiol. 2000 Apr;8(4):189-91
10754579
J Bacteriol. 2004 Aug;186(15):5167-71
15262955
Infect Immun. 2006 Sep;74(9):5391-6
16926434
Nature. 2002 Jun 6;417(6889):642-5
12050664
Biotechnol Adv. 1995;13(2):247-61
14537822
Infect Immun. 1992 Oct;60(10):4430-2
1398956
J Biotechnol. 2007 Jan 1;127(2):188-98
16891024
Mol Imaging Biol. 2008 Jan-Feb;10(1):54-61
17994265
J Infect Dis. 1992 Oct;166(4):837-41
1527420
Infect Immun. 1999 Dec;67(12):6341-5
10569747
Vaccine. 2000 Aug 15;19(1):75-85
10924789
Mol Microbiol. 1998 Feb;27(4):797-805
9515705
Infect Immun. 2008 Oct;76(10):4422-30
18663003
Infect Immun. 2005 Aug;73(8):4488-93
16040959
Infect Immun. 2000 Mar;68(3):1171-5
10678922
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18229-34
17986616
Nat Protoc. 2008;3(4):629-36
18388945
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16669-74
17925449
Infect Immun. 2007 Apr;75(4):1827-34
17145938
Infect Immun. 1998 Apr;66(4):1648-53
9529093
J Bacteriol. 2000 Apr;182(8):2350-3
10735886
EcoSal Plus. 2004 Dec;1(1):
26443366
Infect Immun. 2004 Dec;72(12):7096-106
15557633
Infect Immun. 1999 Dec;67(12):6424-33
10569759
Infect Immun. 2003 Mar;71(3):1352-60
12595452
Mol Microbiol. 2002 Mar;43(6):1471-91
11952899
Mol Genet Genomics. 2005 Sep;274(2):180-8
16047200
Infect Immun. 2008 Sep;76(9):4145-51
18591230